NASDAQ (USD): Kazia Therapeutics Limited (KZIA)
Last Price
0.325
Today's Change
-0.006 (1.81%)
Day's Change
0.315 - 0.33
Trading Volume
198,201
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
World to Pay to Turn Off Green Power Unless Grids Improve
2
Tupperware Files for Bankruptcy as Its Colourful Containers Lose Relevance
3
BlackRock, Microsoft to Raise US$30b for AI Investments
4
Scaramucci Expects Bitcoin Record on Rate Cuts, Clearer US Rules
5
US Housing Starts Increase to Fastest Pace Since April
#
Stock
Score
ZEO
Zeo Energy Corp.
GOOGL
Alphabet Inc.
833
PLTR
Palantir Technologies Inc.
566
BABA
Alibaba Group Holding Limited
AAPL
Apple Inc.
500
6
FB
400
7
AGN
333
8
BAC
Bank of America Corporation
9
CBM
10
ALAI
Alger AI Enablers & Adopters ETF
Last
Change
Volume
XPON
0.102
+0.044
1,392,395,498
NVDA
115.87
-1.991
195,099,978
VERB
0.069
+0.013
150,969,346
CERO
0.11
+0.023
133,302,572
LMDX
0.016
-0.018
120,553,903
SQQQ
7.91
+0.155
117,536,940
NBY
0.752
+0.255
115,144,705
762.00
-84.71
85,558,284
SOXL
32.53
-2.59
81,134,903
HOLO
0.243
+0.012
76,397,362
CEG
251.79
+43.29
10,809,796
RYVLX
530.29
+25.87
0
RYVYX
530.12
+25.86
FCNCA
1,964.10
+24.53
62,262
TPL
935.44
+19.78
58,680
BKNG
4,036.34
+18.83
167,167
RYCCX
381.75
+18.62
CRWD
293.93
+16.55
7,189,975
MOG-B
203.00
+16.48
206
RYSIX
431.84
+15.79
BRK-A
682,262.32
-5,577.687
1,152
MELI
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
NVR
9,522.14
-137.511
9,364
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....